Loading...
Market
Which company will be the first to receive an FDA EUA for a bird flu vaccine by the end of 2024?
2
Declaration of Emergency•Becerra•FDA•Emergency Use Authorizations•EUA•Liverpool•Nigel Hilton•Moderna•HHS•Sinergium Biotech•World Health Organization•WHO
Resolution / Starting Odds
Moderna • 25%
Sinergium Biotech • 25%
Pfizer • 25%
Other • 25%
FDA official announcements and press releases
Story
U.S. Declares Bird Flu Emergency on July 25th, Moderna Secures $176 Million for Vaccine
Jul 29, 2024, 01:00 AM
The U.S. government has issued a Declaration of Emergency on July 25th due to the significant potential for a public health emergency from influenza A viruses with pandemic potential. Secretary Becerra has authorized the FDA Commissioner to issue Emergency Use Authorizations (EUA) for avian flu vaccines. In response, the Liverpool vaccine factory is preparing pre-pandemic H5N1 bird flu vaccines as a first line of defense, according to Nigel Hilton, head of the plant. Moderna has secured a $176 million contract from the HHS to develop a new mRNA vaccine for bird flu. Additionally, Sinergium Biotech will share its bird flu vaccine data with manufacturers in low- and middle-income countries to accelerate a fair rollout if a pandemic occurs, according to the World Health Organization (WHO). This initiative aims to enhance global pandemic preparedness and equitable access to vaccines.
View original story
Similar markets
GSK • 33%
Sanofi • 33%
Seqirus • 33%
WHO • 25%
CDC • 25%
European Medicines Agency (EMA) • 25%
Other • 25%
GSK • 25%
Sanofi • 25%
CSL • 25%
None by deadline • 25%
Pfizer • 25%
Moderna • 25%
Johnson & Johnson • 25%
Other • 25%
Company A • 25%
Company B • 25%
Company C • 25%
Other • 25%
Pfizer • 25%
Johnson & Johnson • 25%
AstraZeneca • 25%
Other • 25%
Pfizer • 25%
Merck • 25%
Zoetis • 25%
Other • 25%
GSK • 25%
Sanofi • 25%
CSL • 25%
Equal distribution • 25%
